- Home
- SYRA vs TCBP Comparison
SYRA vs TCBP Comparison
Compare SYRA & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRA
- TCBP
- Stock Information
- Founded
- SYRA 2020
- TCBP 2013
- Country
- SYRA United States
- TCBP United Kingdom
- Employees
- SYRA N/A
- TCBP N/A
- Industry
- SYRA Other Specialty Stores
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SYRA Industrials
- TCBP Health Care
- Exchange
- SYRA Nasdaq
- TCBP Nasdaq
- Market Cap
- SYRA 5.9M
- TCBP 5.0M
- IPO Year
- SYRA 2023
- TCBP 2022
- Fundamental
- Price
- SYRA $0.49
- TCBP $0.38
- Analyst Decision
- SYRA
- TCBP Strong Buy
- Analyst Count
- SYRA 0
- TCBP 1
- Target Price
- SYRA N/A
- TCBP $2.40
- AVG Volume (30 Days)
- SYRA 4.8M
- TCBP 3.1M
- Earning Date
- SYRA 10-29-2024
- TCBP 11-25-2024
- Dividend Yield
- SYRA N/A
- TCBP N/A
- EPS Growth
- SYRA N/A
- TCBP N/A
- EPS
- SYRA N/A
- TCBP N/A
- Revenue
- SYRA $7,741,558.00
- TCBP N/A
- Revenue This Year
- SYRA $47.74
- TCBP N/A
- Revenue Next Year
- SYRA N/A
- TCBP N/A
- P/E Ratio
- SYRA N/A
- TCBP N/A
- Revenue Growth
- SYRA 35.47
- TCBP N/A
- 52 Week Low
- SYRA $0.34
- TCBP $0.37
- 52 Week High
- SYRA $8.37
- TCBP $32.70
- Technical
- Relative Strength Index (RSI)
- SYRA 51.88
- TCBP 30.77
- Support Level
- SYRA $0.45
- TCBP $0.37
- Resistance Level
- SYRA $0.55
- TCBP $0.47
- Average True Range (ATR)
- SYRA 0.10
- TCBP 0.10
- MACD
- SYRA -0.00
- TCBP 0.01
- Stochastic Oscillator
- SYRA 20.67
- TCBP 2.65
About SYRA Syra Health Corp.
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.